Physician profile
Thomas Freedom
NPI 1073672598
$123,799.50
in general payments reported to CMS, 2019-2025
10 companies · $20K in 2025
The $20K reported for 2025 was more than what 94% of Sleep Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $337).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $14K · 2021: $17K · 2022: $12K · 2023: $27K · 2024: $23K · 2025: $20K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $55K · Travel and Lodging: $7,999 · Consulting Fee: $3,815 · Food and Beverage: $2,654.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $54,940.00 |
| Travel and Lodging | $7,998.69 |
| Consulting Fee | $3,815.00 |
| Food and Beverage | $2,654.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $104,517.55 | 2019-2025 | |
| Harmony Biosciences LLC | $9,379.51 | 2020-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $5,263.73 | 2025 | Lumryz |
| Allergan, INC. | $3,461.29 | 2020-2021 | |
| Inspire Medical Systems, INC. | $818.69 | 2021-2025 | Inspire |
| Eisai INC. | $125.00 | 2019 | |
| Amgen INC. | $92.66 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $84.12 | 2021 | |
| Novartis Pharmaceuticals Corporation | $30.81 | 2025 | |
| Biogen, INC. | $26.14 | 2025 | Skyclarys |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Freedom listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.